HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Jurgen Moll Selected Research

Jurgen Moll Research Topics

Disease

8Neoplasms (Cancer)
01/2021 - 06/2008
1Leukemia
08/2010
1Carcinogenesis
04/2010
1Febrile Neutropenia
11/2009
1Small Cell Lung Carcinoma (Small Cell Lung Cancer)
11/2009
1Hepatocellular Carcinoma (Hepatoma)
09/2009
1Aneuploidy (Aneuploid)
09/2009

Drug/Important Bio-Agent (IBA)

3Pharmaceutical PreparationsIBA
11/2018 - 08/2010
3danusertibIBA
02/2012 - 09/2009
3Aurora KinasesIBA
04/2010 - 09/2009
1Guanosine Triphosphate (GTP)IBA
01/2021
1BI-3406IBA
01/2021
1Mitogen-Activated Protein Kinase Kinases (MEKs)IBA
01/2021
1Oncogene Proteins (Oncogene Protein)IBA
01/2021
1Hormones (Hormone)IBA
11/2018
1Biological ProductsIBA
02/2012
1Biomarkers (Surrogate Marker)IBA
02/2012
1Proteins (Proteins, Gene)FDA Link
02/2012
1N,1,4,4- tetramethyl- 8- ((4- (4- methylpiperazin- 1- yl)phenyl)amino)- 4,5- dihydro- 1H- pyrazolo(4,3- h)quinazoline- 3- carboxamideIBA
08/2010
1CarcinogensIBA
08/2010
1Phosphotransferases (Kinase)IBA
08/2010
1TropomyosinIBA
08/2010
1Retinoblastoma ProteinIBA
08/2010
1Cyclin-Dependent Kinases (cdk Proteins)IBA
08/2010
1EnzymesIBA
04/2010
1Granulocyte Colony-Stimulating Factor (G-CSF)IBA
11/2009
1Sorafenib (BAY 43-9006)FDA Link
09/2009
1Histones (Histone)IBA
09/2009
1PHA 767491IBA
06/2008

Therapy/Procedure

1Oral Administration
08/2010
1Therapeutics
04/2010